by RG | Jun 15, 2026 | above the law
Ed. note: Welcome to our daily feature, Quote of the Day. If the original Magic Circle was defined by prestige, complexity and pricing power, then London already has a new one. Kirkland & Ellis. Latham & Watkins. Paul Weiss. Simpson Thacher & Bartlett....
by RG | Jun 15, 2026 | above the law
The Trump “Anti-Weaponization Fund” — the $1.776 billion slush fund the DOJ announced in May without congressional authorization, to pay out Trump allies including January 6 rioters, administered by Trump’s personal lawyer turned Acting Attorney General Todd Blanche,...
by RG | Jun 15, 2026 | above the law
This weekend, two formerly lauded public institutions humiliated themselves in spectacular fashion. By Sunday, one was shrouded in thousands of yards of tarpaulin — a translucent prophylactic, hiding an old man’s flaccid defeat. The other dangled limply in the breeze,...
by RG | Jun 15, 2026 | above the law
Ed. note: Please welcome Renee Knake Jefferson back to the pages of Above the Law. Subscribe to her Substack, Legal Ethics Roundup, here. Welcome to what captivates, haunts, inspires, and surprises me every week in the world of legal ethics. Happy Monday! Hello from...
by RG | Jun 15, 2026 | above the law
Litigation is beginning to resemble something lawyers are rarely trained to recognize. Product management. Not in the superficial sense of dashboards or metrics, but in the deeper sense of modular design, version control, internal ownership, feedback loops, and...
by RG | Jun 15, 2026 | above the law
The post Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs appeared first on Above the Law.The post Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs appeared first on Above the Law.
